Palatin Technologies, Inc. Common Stock (PTN)

Price$14.15

Value ScoreB

Growth ScoreA

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-35.51%

Price vs S&P 500 (4W)-27.31%

VGM Score74.76

Market Capitalization$25.18M

All Metrics

Book Value / Share (Quarterly)$5.96

P/TBV (Annual)196.73x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-8.44

Price vs S&P 500 (YTD)-16.15%

Gross Margin (TTM)97.83%

Net Profit Margin (TTM)-31.20%

EPS (TTM)$-1.69

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-1.69

EPS (Annual)$-32.15

ROI (Annual)-9180.00%

Gross Margin (Annual)97.83%

Net Profit Margin (5Y Avg)-4465.01%

Cash / Share (Quarterly)$5.72

ROA (Last FY)-529.77%

Revenue Growth TTM (YoY)3581.22%

EBITD / Share (TTM)$-3.07

ROE (5Y Avg)-5564.42%

Operating Margin (TTM)-32.97%

Cash Flow / Share (Annual)$-22.92

P/B Ratio2.38x

P/B Ratio (Quarterly)2.91x

Net Income / Employee (Annual)$-596,800

EV / Revenue (TTM)1.17x

Net Interest Coverage (TTM)-159.00x

ROA (TTM)-58.08%

EV / EBITDA (TTM)0.42x

EPS Incl Extra (Annual)$-32.15

Current Ratio (Annual)0.36x

Quick Ratio (Quarterly)4.93x

3-Month Avg Trading Volume0.02M

52-Week Price Return157.29%

Revenue / Employee (TTM)$444,300

Tangible BV / Share (Quarterly)$-0.41

P/S Ratio (Annual)5.61x

Asset Turnover (Annual)0.42x

52-Week High$31.00

Operating Margin (5Y Avg)-4655.03%

EPS Excl Extra (Annual)$-32.15

Tangible BV CAGR (5Y)-65.38%

26-Week Price Return-27.58%

Quick Ratio (Annual)0.33x

13-Week Price Return-36.26%

Total Debt / Equity (Annual)2.00x

Current Ratio (Quarterly)5.04x

Enterprise Value$15.02M

Asset Turnover (TTM)0.97x

Book Value / Share Growth (5Y)-69.76%

Revenue / Employee (Annual)$0

Inventory Turnover (Annual)0.39x

Pretax Margin (Annual)-662.26%

Cash / Share (Annual)$2.76

3-Month Return Std Dev77.94%

Gross Margin (5Y Avg)94.88%

Net Income / Employee (TTM)$-215,500

ROE (Last FY)-27540.00%

Net Interest Coverage (Annual)-50.33x

EPS Basic Excl Extra (Annual)$-32.15

P/FCF (TTM)6.61x

Receivables Turnover (TTM)3.10x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-1.69

Receivables Turnover (Annual)3.10x

ROI (TTM)-53.70%

P/S Ratio (TTM)1.95x

Pretax Margin (5Y Avg)-4484.31%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.01

Price vs S&P 500 (52W)132.92%

Year-to-Date Return-7.99%

5-Day Price Return-3.14%

EPS Normalized (Annual)$-32.15

ROA (5Y Avg)-222.13%

Net Profit Margin (Annual)-662.26%

Month-to-Date Return0.93%

Cash Flow / Share (TTM)$-2.16

EBITD / Share (Annual)$-31.95

Operating Margin (Annual)-501.02%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-1891.63%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.69

P/B Ratio (Annual)241.99x

Inventory Turnover (TTM)0.39x

Pretax Margin (TTM)-31.20%

Book Value / Share (Annual)$0.01

Price vs S&P 500 (13W)-44.51%

Beta0.56x

P/FCF (Annual)0.61x

Revenue / Share (TTM)$3.29

ROE (TTM)-53.70%

52-Week Low$4.50

vGradeB

gGradeA

mGradeC

vgmGradeB

Show chart for

Earnings Surprise History

Q3 26-0.37est. -1.26

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.00

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
PTNPalatin Technologies, Inc. Common Stock	B	A	C	$14.15
LLYEli Lilly & Co.	D	B	B	$1131.42
JNJJohnson & Johnson	D	C	B	$232.77
ABBVABBVIE INC.	D	C	C	$227.23
MRKMerck & Co., Inc.	C	C	B	$120.79
NVSNovartis AG	C	C	C	$149.16
AZNAstraZeneca PLC	D	B	C	$185.95
NVONovo-Nordisk A/S	B	B	B	$42.96
ABTAbbott Laboratories	C	C	D	$91.07
PFEPfizer Inc.	B	C	C	$26.04
BMYBristol-Myers Squibb Co.	B	C	B	$57.27

About

Palatin Technologies is a biopharmaceutical company developing first-in-class, receptor-specific medicines that modulate the melanocortin receptor system. The company targets diseases with unmet medical needs and significant commercial potential. Palatin operates as a focused life science business.